Searching. Please wait…
1580
37
170
29264
4420
2603
347
391
Abstract: Neuroblastoma (NB) is a childhood cancer in sympathetic nervous system cells. NB exhibits cellular heterogeneity, with adrenergic and mesenchymal states displaying distinct tumorigenic potentials. NB is highly vascularized, and blood vessels can form through various mechanisms, including endothelial transdifferentiation, leading to the development of tumor-derived endothelial cells (TECs) associated with chemoresistance. We lack specific biomarkers for TECs. Therefore, identifying new TEC biomarkers is vital for effective NB therapies. A stiffness-based platform simulating human arterial and venous stiffness was developed to study NB TECs in vitro. Adrenergic cells cultured on arterial-like stiffness transdifferentiated into TECs, while mesenchymal state cells did not. The TECs derived from adrenergic cells served as a model to explore new biomarkers, with a particular focus on GB3, a glycosphingolipid receptor implicated in angiogenesis, metastasis, and drug resistance. Notably, the TECs unequivocally expressed GB3, validating its novelty as a marker. To explore targeted therapeutic interventions, nanoparticles functionalized with the non-toxic subunit B of the Shiga toxin were generated, because they demonstrated a robust affinity for GB3-positive cells. Our results demonstrate the value of the stiffness-based platform as a predictive tool for assessing NB aggressiveness, the discovery of new biomarkers, and the evaluation of the effectiveness of targeted therapeutic strategies
Fuente: Cancers, 2024, 16(5), 1060
Editorial: MDPI
Año de publicación: 2024
Nº de páginas: 15
Tipo de publicación: Artículo de Revista
DOI: 10.3390/cancers16051060
ISSN: 2072-6694
Url de la publicación: https://doi.org/10.3390/cancers16051060
Consultar en UCrea Leer publicación
VILLASANTE, ARANZAZU
COROMINAS, JOSEP
ALCON, CLARA
GARCÍA-LIZARRIBAR, ANDREA
MORA, JAUME
MONICA LOPEZ FANARRAGA
SAMITIER, JOSEP
Volver